Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology.

• Maack C Comprehensive Heart Failure Center, University Clinic Würzburg, Würzburg, Germany.
• Lehrke M Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany.
• Backs J Department of Molecular Cardiology and Epigenetics, University of Heidelberg, Heidelberg, Germany.
• Heinzel FR Department of Cardiology, Charité-Universitätsmedizin, Berlin, Germany.
• Hulot JS Paris Cardiovascular Research Center PARCC, INSERM UMR970, CIC 1418, and F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Paris, France.
• Marx N Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany.
• Paulus WJ Department of Physiology, VU University Medical Center, Amsterdam, The Netherlands.
• Rossignol P Inserm, Centre d'Investigations Cliniques-Plurithématique 14-33, Inserm U1116, CHRU Nancy, Université de Lorraine, and F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.
• Taegtmeyer H Department of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.
• Bauersachs J Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
• Bayes-Genis A Heart Failure Unit and Cardiology Service, Hospital Universitari Germans Trias i Pujol, CIBERCV, Badalona, Spain.
• Brutsaert D Prof-Emer, University of Antwerp, Antwerp, Belgium.
• Bugger H Cardiology and Angiology, Heart Center, University of Freiburg, Freiburg, Germany.
• Clarke K Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.
• Cosentino F Department of Medicine Solna, Cardiology Unit, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
• De Keulenaer G Laboratory of Physiopharmacology, University of Antwerp, Antwerp, Belgium.
• Dei Cas A Department of Medicine and Surgery, Endocrinology and Metabolism, University of Parma, Parma, Italy.
• González A Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, Pamplona and CIBERCV, Carlos III Institute of Health, Madrid, Spain.
• Huelsmann M Division of Cardiology, Department of Medicine II, Medical University of Vienna, Vienna, Austria.
• Iaccarino G Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi, Italy.
• Lunde IG Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Oslo, Norway.
• Lyon AR Cardiovascular Research Centre, Royal Brompton Hospital; National Heart and Lung Institute, Imperial College London, London, UK.
• Pollesello P Faculty of Medicine, University of Helsinki, Helsinki, Finland.
• Rena G Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.
• Riksen NP Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
• Rosano G Cardiovascular Clinical Academic Group, St George's Hospitals NHS Trust University of London, London, UK.
• Staels B University of Lille-EGID, Lille, France.
• van Laake LW Department of Cardiology, Heart and Lungs Division, and Regenerative Medicine Centre, University Medical Centre Utrecht, Utrecht, the Netherlands.
• Wanner C Würzburg University Clinic, Würzburg, Germany.
• Farmakis D Heart Failure Unit, Athens University Hospital Attikon, National and Kapodistrian University of Athens, Athens, Greece.
• Filippatos G Heart Failure Unit, Athens University Hospital Attikon, National and Kapodistrian University of Athens, Athens, Greece.
• Ruschitzka F University Heart Centre, University Hospital Zurich, Zurich, Switzerland.
• Seferovic P Department of Cardiology, Belgrade University Medical Centre, Belgrade, Serbia.
• de Boer RA Department of Cardiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
• Heymans S Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, The Netherlands.

Show more…

Aged

Aged, 80 and over

Comorbidity

Diabetes Mellitus

Europe

Female

Heart Failure

Humans

Hypoglycemic Agents

Insulin Resistance

Male

Obesity

Renal Insufficiency, Chronic

Societies, Medical

Socioeconomic Factors

Sulfonylurea Compounds

Translational Medical Research